Attached files
| file | filename |
|---|---|
| S-1/A - Arno Therapeutics, Inc | v208078_s1a.htm |
| EX-23.1 - Arno Therapeutics, Inc | v208078_ex23-1.htm |
| EX-10.16 - Arno Therapeutics, Inc | v208078_ex10-16.htm |
| EX-10.15 - Arno Therapeutics, Inc | v208078_ex10-15.htm |
Exhibit
23.2
Consent of Independent Registered
Public Accounting Firm
We
consent to the use in this Pre-effective Amendment No. 1 to the Registration
Statement of Arno Therapeutics, Inc. on Form S-1 of our report dated March 31,
2009, on the financial statements of Arno Therapeutics, Inc. and to the
reference to us under the heading “Experts” in the prospectus.
|
/s/
Hays & Company
LLP
|
|
New
York, New York
|
|
January
18, 2011
|